Porphyria Cutanea Tarda, Hepatitis C, Uroporphyrinogen Decarboxylase and Mutations of HFE Gene

Dermatology ◽  
2009 ◽  
Vol 218 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Bernard Cribier ◽  
Christine Chiaverini ◽  
Nassim Dali-Youcef ◽  
Michèle Schmitt ◽  
Michèle Grima ◽  
...  
2013 ◽  
Vol 88 (4) ◽  
pp. 530-540 ◽  
Author(s):  
Fatima Mendonca Jorge Vieira ◽  
Maria Cristina Nakhle ◽  
Clarice Pires Abrantes-Lemos ◽  
Eduardo Luiz Rachid Cancado ◽  
Vitor Manoel Silva dos Reis

BACKGROUND: Porphyria cutanea tarda is the most common form of porphyria, characterized by the decreased activity of the uroporphyrinogen decarboxylase enzyme. Several reports associated HFE gene mutations of hereditary hemochromatosis with porphyria cutanea tarda worldwide, although up to date only one study has been conducted in Brazil. OBJECTIVES: Investigation of porphyria cutanea tarda association with C282Y and H63D mutations in the HFE gene. Identification of precipitating factors (hepatitis C, HIV, alcoholism and estrogen) and their link with HFE mutations. METHODS: An ambispective study of 60 patients with PCT was conducted during the period from 2003 to 2012. Serological tests for hepatitis C and HIV were performed and histories of alcohol abuse and estrogen intake were investigated. HFE mutations were identified with real-time PCR. RESULTS: Porphyria cutanea tarda predominated in males and alcohol abuse was the main precipitating factor. Estrogen intake was the sole precipitating factor present in 25% of female patients. Hepatitis C was present in 41.7%. All HIV-positive patients (15.3%) had a history of alcohol abuse. Allele frequency for HFE mutations, i.e., C282Y (p = 0.0001) and H63D (p = 0.0004), were significantly higher in porphyria cutanea tarda patients, compared to control group. HFE mutations had no association with the other precipitating factors. CONCLUSIONS: Alcohol abuse, hepatitis C and estrogen intake are prevalent precipitating factors in our porphyria cutanea tarda population; however, hemochromatosis in itself can also contribute to the outbreak of porphyria cutanea tarda, which makes the research for HFE mutations necessary in these patients


Dermatology ◽  
2003 ◽  
Vol 206 (3) ◽  
pp. 212-216 ◽  
Author(s):  
Christine Chiavérini ◽  
Gilles Halimi ◽  
Denis Ouzan ◽  
Philippe Halfon ◽  
Jean-Paul Ortonne ◽  
...  

Hepatology ◽  
1998 ◽  
Vol 27 (6) ◽  
pp. 1661-1669 ◽  
Author(s):  
Herbert L. Bonkovsky ◽  
Maureen Poh-Fitzpatrick ◽  
Neville Pimstone ◽  
Jorge Obando ◽  
Adrian Di Bisceglie ◽  
...  

2021 ◽  
Vol 2 (3) ◽  
pp. 96-98
Author(s):  
Carlan SJ

Background Porphyria CutaneaTarda (PCT) is the most common type of porphyria and is caused by a decrease in the activity of the hepatic enzyme uroporphyrinogen decarboxylase. It is expressed in both a sporadic form and genetic form and typically presents with cutaneous manifestations described as skin blisters in sun exposed areas. Case A 54-year-old male presented complaining of bullous itchy lesions on his hands and upper extremities that were at different stages of healing. Lab results were consistent with porphyria including elevated serum total porphyrins. He was scheduled for phlebotomy every other week for six weeks, hydroxychloroquine, minimize any sun exposure and to completely stop smoking. Conclusion Widespread skin lesions associated with underlying liver disease is a characteristic presentation for PCT. Hepatitis C is an antecedent risk factor for PCT, but can now be treated with antiviral therapy with the expectation of attainment of a sustained virologic response. Improvements in arresting progressive liver disease in Hepatitis C patients may improve PCT symptoms, as well. Keywords: Porphyria CutaneaTarda; Hepatitis C; Acquired liver disease.


2000 ◽  
Vol 32 ◽  
pp. 113 ◽  
Author(s):  
P. Lebray ◽  
H. Zylberberg ◽  
S. Hue ◽  
S. Martin ◽  
Y. Chrétien ◽  
...  

Kanzo ◽  
1999 ◽  
Vol 40 (6) ◽  
pp. 350-354 ◽  
Author(s):  
Kazufumi DOHMEN ◽  
Shingo ONOHARA ◽  
Hironari AJIBE ◽  
Masafumi SHIRAHAMA ◽  
Yuichi MIYAMOTO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document